{'fraction_non_alphanumeric': 0.01849217638691323, 'fraction_numerical': 0.007112375533428165, 'mean_word_length': 5.579439252336448, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[When is lipid-lowering therapy appropriate for stroke?].

The results of the secondary preventive care cardiological studies, 4S and CARE, which showed treatment with statins to yield a 30 per cent reduction in the frequency of cardiovascular events, are not directly transposable to stroke care, mainly because the mean age of the patients studied was 15 years less than that of typical stroke populations. However, results obtained in both epidemiological and randomised clinical studies of patients with coronary heart disease suggest that cholesterol-lowering medication might prove to be an important feature of secondary preventive treatment following minor stroke or transient ischaemie attacks.